World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Top Biotechnology Companies in the World as of Jul. 01, 2024

Rank Company Market Cap (USD) Country Sector Industry
691 AnteoTech Limited $32.9 M Australia Australian Healthcare Australian Biotechnology
692 Longeveron, Inc. $32.4 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
693 Delta-Fly Pharma, Inc. $30.9 M Japan Japanese Healthcare Japanese Biotechnology
694 Oxford BioDynamics plc $30.2 M United Kingdom UK Healthcare UK Biotechnology
695 Gain Therapeutics, Inc. $30.2 M United States US Healthcare US Biotechnology
696 VYNE Therapeutics Inc. $30.1 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
697 Angion Biomedica Corp $30.1 M

(June 1, 2023)

 United States US Healthcare US Biotechnology
698 Evaxion Biotech A/S $28.8 M

(Jan. 1, 2024)

 Denmark Danish Healthcare Danish Biotechnology
699 Mawson Infrastructure Group, Inc. $28.6 M Australia Australian Healthcare Australian Biotechnology
700 Moleculin Biotech, Inc. $28.1 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
701 Enlivex Therapeutics Ltd. $27.9 M Israel Israeli Healthcare Israeli Biotechnology
702 Freeline Therapeutics Holdings plc $27.6 M

(Jan. 1, 2024)

 United Kingdom UK Healthcare UK Biotechnology
703 Iterum Therapeutics plc $27.0 M

(Jan. 1, 2024)

 Ireland Irish Healthcare Irish Biotechnology
704 Ultimovacs ASA $25.9 M Norway Norway Healthcare Norway Biotechnology
705 Valbiotis SA $25.7 M France French Healthcare French Biotechnology
706 Vincera Pharma, Inc. $25.2 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
707 OptiBiotix Health plc $23.5 M United Kingdom UK Healthcare UK Biotechnology
708 Biotron Limited $23.4 M Australia Australian Healthcare Australian Biotechnology
709 Spruce Biosciences, Inc. $23.4 M United States US Healthcare US Biotechnology
710 SkinBioTherapeutics plc $23.2 M United Kingdom UK Healthcare UK Biotechnology
711 Portage Biotech, Inc. $21.6 M

(Jan. 1, 2024)

 Virgin Islands (British) Virgin Islands (British) Healthcare Virgin Islands (British) Biotechnology
712 Yumanity Therapeutics, Inc. $20.5 M

(Dec. 1, 2022)

 United States US Healthcare US Biotechnology
713 NLS Pharmaceutics AG $20.0 M

(Jan. 1, 2024)

 Switzerland Swiss Healthcare Swiss Biotechnology
714 Sensei Biotherapeutics, Inc. $19.2 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
715 Galecto, Inc. $19.2 M

(Jan. 1, 2024)

 Denmark Danish Healthcare Danish Biotechnology
716 NeuroBo Pharmaceuticals, Inc. $18.8 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
717 Aprea Therapeutics, Inc. $18.8 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
718 Metacrine, Inc. $18.8 M

(Jan. 1, 2023)

 United States US Healthcare US Biotechnology
719 Cocrystal Pharma, Inc. $18.5 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
720 Vascular Biogenics Ltd. $18.3 M

(July 1, 2023)

 Israel Israeli Healthcare Israeli Biotechnology

Top Biotechnology Companies in the World as of Jul. 01, 2024

691. AnteoTech Limited

Company Profile: AnteoTech Limited
Market Cap (USD): $32.9 M
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

692. Longeveron, Inc.

Company Profile: Longeveron, Inc.
Market Cap (USD): $32.4 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

693. Delta-Fly Pharma, Inc.

Company Profile: Delta-Fly Pharma, Inc.
Market Cap (USD): $30.9 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Biotechnology

694. Oxford BioDynamics plc

Company Profile: Oxford BioDynamics plc
Market Cap (USD): $30.2 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

695. Gain Therapeutics, Inc.

Company Profile: Gain Therapeutics, Inc.
Market Cap (USD): $30.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

696. VYNE Therapeutics Inc.

Company Profile: VYNE Therapeutics Inc.
Market Cap (USD): $30.1 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

697. Angion Biomedica Corp

Company Profile: Angion Biomedica Corp
Market Cap (USD): $30.1 M (June 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

698. Evaxion Biotech A/S

Company Profile: Evaxion Biotech A/S
Market Cap (USD): $28.8 M (Jan. 1, 2024)
Country: Denmark
Sector: Danish Healthcare
Industry: Danish Biotechnology

699. Mawson Infrastructure Group, Inc.

Company Profile: Mawson Infrastructure Group, Inc.
Market Cap (USD): $28.6 M
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

700. Moleculin Biotech, Inc.

Company Profile: Moleculin Biotech, Inc.
Market Cap (USD): $28.1 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

701. Enlivex Therapeutics Ltd.

Company Profile: Enlivex Therapeutics Ltd.
Market Cap (USD): $27.9 M
Country: Israel
Sector: Israeli Healthcare
Industry: Israeli Biotechnology

702. Freeline Therapeutics Holdings plc

Company Profile: Freeline Therapeutics Holdings plc
Market Cap (USD): $27.6 M (Jan. 1, 2024)
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

703. Iterum Therapeutics plc

Company Profile: Iterum Therapeutics plc
Market Cap (USD): $27.0 M (Jan. 1, 2024)
Country: Ireland
Sector: Irish Healthcare
Industry: Irish Biotechnology

704. Ultimovacs ASA

Company Profile: Ultimovacs ASA
Market Cap (USD): $25.9 M
Country: Norway
Sector: Norway Healthcare
Industry: Norway Biotechnology

705. Valbiotis SA

Company Profile: Valbiotis SA
Market Cap (USD): $25.7 M
Country: France
Sector: French Healthcare
Industry: French Biotechnology

706. Vincera Pharma, Inc.

Company Profile: Vincera Pharma, Inc.
Market Cap (USD): $25.2 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

707. OptiBiotix Health plc

Company Profile: OptiBiotix Health plc
Market Cap (USD): $23.5 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

708. Biotron Limited

Company Profile: Biotron Limited
Market Cap (USD): $23.4 M
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

709. Spruce Biosciences, Inc.

Company Profile: Spruce Biosciences, Inc.
Market Cap (USD): $23.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

710. SkinBioTherapeutics plc

Company Profile: SkinBioTherapeutics plc
Market Cap (USD): $23.2 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

711. Portage Biotech, Inc.

Company Profile: Portage Biotech, Inc.
Market Cap (USD): $21.6 M (Jan. 1, 2024)
Country: Virgin Islands (British)
Sector: Virgin Islands (British) Healthcare
Industry: Virgin Islands (British) Biotechnology

712. Yumanity Therapeutics, Inc.

Company Profile: Yumanity Therapeutics, Inc.
Market Cap (USD): $20.5 M (Dec. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

713. NLS Pharmaceutics AG

Company Profile: NLS Pharmaceutics AG
Market Cap (USD): $20.0 M (Jan. 1, 2024)
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

714. Sensei Biotherapeutics, Inc.

Company Profile: Sensei Biotherapeutics, Inc.
Market Cap (USD): $19.2 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

715. Galecto, Inc.

Company Profile: Galecto, Inc.
Market Cap (USD): $19.2 M (Jan. 1, 2024)
Country: Denmark
Sector: Danish Healthcare
Industry: Danish Biotechnology

716. NeuroBo Pharmaceuticals, Inc.

Company Profile: NeuroBo Pharmaceuticals, Inc.
Market Cap (USD): $18.8 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

717. Aprea Therapeutics, Inc.

Company Profile: Aprea Therapeutics, Inc.
Market Cap (USD): $18.8 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

718. Metacrine, Inc.

Company Profile: Metacrine, Inc.
Market Cap (USD): $18.8 M (Jan. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

719. Cocrystal Pharma, Inc.

Company Profile: Cocrystal Pharma, Inc.
Market Cap (USD): $18.5 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

720. Vascular Biogenics Ltd.

Company Profile: Vascular Biogenics Ltd.
Market Cap (USD): $18.3 M (July 1, 2023)
Country: Israel
Sector: Israeli Healthcare
Industry: Israeli Biotechnology

Top 1-year algo backtest: +265.99% - Try Disfold DeepFinance for FREE now!

Stay in touch